<p class="title">Caffeine consumption may prolong the lifespan of patients with chronic kidney disease, a study claims.</p>.<p class="bodytext">Researchers at Centro Hospitalar Lisboa Norte in Portugal examined the association of caffeine consumption with mortality among 2328 patients with chronic kidney disease (CKD).</p>.<p class="bodytext">The team found a dose-dependent inverse association between caffeine and all-cause mortality.</p>.<p class="bodytext">Compared with those in the lowest quartile of caffeine consumption, those in the second, third, and highest quartiles had 12 percent, 22 percent, and 24 percent lower risks of dying.</p>.<p class="bodytext">"Our study showed a dose-dependent protective effect of caffeine consumption on mortality among patients with CKD," said Miguel Bigotte Vieira from Centro Hospitalar Lisboa Norte.</p>.<p class="bodytext">This association was independent of potential confounders including age, gender, race, annual family income, education level hypertension, smoking status etc, researchers said.</p>.<p class="bodytext">"These results suggest that advising patients with CKD to drink more caffeine may reduce their mortality. This would represent a simple, clinically beneficial, and inexpensive option, though this benefit should ideally be confirmed in a randomised clinical trial," said Vieira.</p>
<p class="title">Caffeine consumption may prolong the lifespan of patients with chronic kidney disease, a study claims.</p>.<p class="bodytext">Researchers at Centro Hospitalar Lisboa Norte in Portugal examined the association of caffeine consumption with mortality among 2328 patients with chronic kidney disease (CKD).</p>.<p class="bodytext">The team found a dose-dependent inverse association between caffeine and all-cause mortality.</p>.<p class="bodytext">Compared with those in the lowest quartile of caffeine consumption, those in the second, third, and highest quartiles had 12 percent, 22 percent, and 24 percent lower risks of dying.</p>.<p class="bodytext">"Our study showed a dose-dependent protective effect of caffeine consumption on mortality among patients with CKD," said Miguel Bigotte Vieira from Centro Hospitalar Lisboa Norte.</p>.<p class="bodytext">This association was independent of potential confounders including age, gender, race, annual family income, education level hypertension, smoking status etc, researchers said.</p>.<p class="bodytext">"These results suggest that advising patients with CKD to drink more caffeine may reduce their mortality. This would represent a simple, clinically beneficial, and inexpensive option, though this benefit should ideally be confirmed in a randomised clinical trial," said Vieira.</p>